The CADTH clinical review concluded that, based on the currently available evidence, there was no strong evidence to suggest a quality-of-life benefit for oral semaglutide compared to other antidiabetic treatments
Also, patients taking GLP-1s who have any gastrointestinal side effects -- nausea, vomiting, abdominal pain, shortness of breath or constipation -- should wait till these symptoms ease before undergoing surgery
The mandatory survey launched on April 30
Cosmetic use Dix also expressed concern over the shift in use of weight-loss drugs from a medical necessity to 'cosmetic' use, especially by those aspiring to have a 'perfect' body shape
While recent case reports have suggested a possible link with GLP-1RA therapy and ION risk (particularly non-arteritic anterior ischaemic optic neuropathy), large-scale analyses examining formulation-specific risk have been lacking